Zealand Pharma Current Ratio 2017-2019 | ZLDPF

Zealand Pharma current ratio from 2017 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Zealand Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.24B $0.05B 5.18
2019-06-30 $0.18B $0.04B 4.48
2019-03-31 $0.20B $0.04B 4.86
2018-12-31 $0.19B $0.02B 10.39
2018-09-30 $0.23B $0.04B 5.30
2018-06-30 $0.08B $0.01B 7.82
2018-03-31 $0.10B $0.01B 11.17
2017-12-31 $0.11B $0.01B 9.28
2017-09-30 $0.13B $0.01B 12.63
2017-06-30 $0.05B $0.01B 6.39
2017-03-31 $0.07B $0.01B 4.81
2016-12-31 $0.06B $0.01B 4.26
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.881B $0.006B
Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.199B 14.09
Gilead Sciences (GILD) United States $96.919B 12.54
CSL (CSLLY) Australia $87.050B 0.00
Vertex Pharmaceuticals (VRTX) United States $62.784B 56.98
Regeneron Pharmaceuticals (REGN) United States $54.871B 23.24
Biogen (BIIB) United States $52.997B 9.05
Illumina (ILMN) United States $40.130B 41.49
Seattle Genetics (SGEN) United States $20.442B 0.00
Alexion Pharmaceuticals (ALXN) United States $20.067B 9.30
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $16.707B 35.85
BioMarin Pharmaceutical (BMRN) United States $15.484B 662.00
Genmab (GMAB) Denmark $13.068B 10.25
BioNTech SE (BNTX) Germany $12.877B 0.00
Genmab (GNMSF) Denmark $12.366B 39.77
Galapagos (GLPG) Belgium $12.288B 26.84
Alnylam Pharmaceuticals (ALNY) United States $11.783B 0.00
Moderna (MRNA) United States $10.923B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.315B 48.21
QIAGEN (QGEN) Netherlands $9.133B 27.85
BeiGene (BGNE) Cayman Islands $8.882B 0.00
Exact Sciences (EXAS) United States $8.523B 0.00
Sarepta Therapeutics (SRPT) United States $7.465B 0.00
Bio-Techne Corp (TECH) United States $7.318B 50.08
ACADIA Pharmaceuticals (ACAD) United States $6.475B 0.00
Guardant Health (GH) United States $6.146B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.056B 16.00
ARGENX SE-ADR (ARGX) Netherlands $5.695B 0.00
Ascendis Pharma (ASND) Denmark $5.293B 0.00
Exelixis (EXEL) United States $5.085B 16.32
Repligen (RGEN) United States $5.050B 92.33
Reata Pharmaceuticals (RETA) United States $4.498B 0.00
Acceleron Pharma (XLRN) United States $4.459B 0.00
China Biologic Products (CBPO) China $4.023B 23.88
Adaptive Biotechnologies (ADPT) United States $3.553B 0.00
Mirati Therapeutics (MRTX) United States $3.278B 0.00
Blueprint Medicines (BPMC) United States $3.263B 0.00
Vir Biotechnology (VIR) United States $3.213B 0.00
MorphoSys AG (MOR) Germany $3.186B 0.00
Global Blood Therapeutics (GBT) United States $3.076B 0.00
Zai Lab (ZLAB) China $2.992B 0.00
Emergent Biosolutions (EBS) United States $2.966B 20.59
Ultragenyx Pharmaceutical (RARE) United States $2.896B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.845B 0.00
NeoGenomics (NEO) United States $2.834B 122.86
Amicus Therapeutics (FOLD) United States $2.472B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.404B 40.73
Bluebird Bio (BLUE) United States $2.370B 0.00
Halozyme Therapeutics (HALO) United States $2.329B 0.00
Immunomedics (IMMU) United States $2.278B 0.00
Alkermes (ALKS) Ireland $2.212B 175.25
Arena Pharmaceuticals (ARNA) United States $2.210B 5.76
MyoKardia (MYOK) United States $2.161B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.102B 0.00
UniQure (QURE) Netherlands $2.078B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.977B 0.00
Amarin (AMRN) Ireland $1.865B 0.00
Denali Therapeutics (DNLI) United States $1.839B 0.00
Alector (ALEC) United States $1.786B 0.00
Principia Biopharma (PRNB) United States $1.731B 0.00
Eidos Therapeutics (EIDX) United States $1.647B 0.00
Viela Bio (VIE) United States $1.631B 0.00
Fate Therapeutics (FATE) United States $1.600B 0.00
Arvinas (ARVN) United States $1.565B 0.00
Zymeworks (ZYME) Canada $1.563B 0.00
Akcea Therapeutics (AKCA) United States $1.463B 31.46
Epizyme (EPZM) United States $1.437B 0.00
Insmed (INSM) United States $1.357B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.350B 0.00
Ligand Pharmaceuticals (LGND) United States $1.188B 36.90
Zealand Pharma (ZEAL) Denmark $1.144B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Editas Medicine (EDIT) United States $1.096B 0.00
Inovio Pharmaceuticals (INO) United States $1.096B 0.00
REGENXBIO (RGNX) United States $1.093B 0.00
Coherus BioSciences (CHRS) United States $1.057B 12.57
Twist Bioscience (TWST) United States $1.055B 0.00
Myriad Genetics (MYGN) United States $0.992B 17.51
NextCure (NXTC) United States $0.987B 0.00
NGM Biopharmaceuticals (NGM) United States $0.866B 0.00
I-Mab (IMAB) China $0.827B 0.00
Intra-Cellular Therapies (ITCI) United States $0.795B 0.00
Sangamo Therapeutics (SGMO) United States $0.787B 0.00
Revance Therapeutics (RVNC) United States $0.779B 0.00
Beam Therapeutics (BEAM) United States $0.758B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.740B 0.00
Cytokineticsorporated (CYTK) United States $0.716B 0.00
Novavax (NVAX) United States $0.714B 0.00
Arcus Biosciences (RCUS) United States $0.685B 0.00
Adverum Biotechnologies (ADVM) United States $0.680B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Bellus Health (BLU) Canada $0.663B 0.00
Athenex (ATNX) United States $0.658B 0.00
Retrophin (RTRX) United States $0.648B 0.00
Kadmon Holdings (KDMN) United States $0.617B 0.00
Codexis (CDXS) United States $0.613B 0.00
Cara Therapeutics (CARA) United States $0.593B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.591B 5.20
Intellia Therapeutics (NTLA) United States $0.582B 0.00
GENFIT S.A (GNFT) France $0.577B 0.00
AC Immune SA (ACIU) Switzerland $0.512B 13.07
ZIOPHARM Oncology Inc (ZIOP) United States $0.509B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.501B 0.00
Compugen (CGEN) Israel $0.497B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
Mesoblast (MESO) Australia $0.486B 0.00
Intrexon (PGEN) United States $0.485B 0.00
Castle Biosciences (CSTL) United States $0.477B 0.00
Frequency Therapeutics (FREQ) United States $0.474B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.469B 0.00
ANI Pharmaceuticals (ANIP) United States $0.469B 8.46
Heska (HSKA) United States $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.460B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
Athersys (ATHX) United States $0.450B 0.00
Clovis Oncology (CLVS) United States $0.446B 0.00
MeiraGTx Holdings (MGTX) United States $0.434B 0.00
Morphic Holding (MORF) United States $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.430B 0.00
Anika Therapeutics (ANIK) United States $0.421B 14.48
Aquinox Pharmaceuticals (NLTX) United States $0.414B 0.00
Verastem (VSTM) United States $0.411B 0.00
Vericel (VCEL) United States $0.387B 57.47
Xenon Pharmaceuticals (XENE) Canada $0.384B 0.00
Agenus (AGEN) United States $0.383B 0.00
Scholar Rock Holding (SRRK) United States $0.381B 0.00
Cel-Sci (CVM) United States $0.374B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.373B 0.00
AnaptysBio (ANAB) United States $0.368B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
BioDelivery Sciences (BDSI) United States $0.364B 42.00
MiMedx (MDXG) United States $0.361B 0.00
UROGEN PHARMA (URGN) United States $0.355B 0.00
Cellectis S.A (CLLS) France $0.349B 0.00
Kala Pharmaceuticals (KALA) United States $0.346B 0.00
CytomX Therapeutics (CTMX) United States $0.340B 0.00
Cue Biopharma (CUE) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.337B 10.11
Merus (MRUS) Netherlands $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.298B 0.00
Dynavax Technologies (DVAX) United States $0.298B 0.00
Pfenex (PFNX) United States $0.298B 435.00
Syndax Pharmaceuticals (SNDX) United States $0.295B 0.00
Puma Biotechnology (PBYI) United States $0.286B 0.00
Precision BioSciences (DTIL) United States $0.285B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
NantKwest (NK) United States $0.261B 0.00
Kamada (KMDA) Israel $0.252B 10.50
Syros Pharmaceuticals (SYRS) United States $0.249B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Stemline Therapeutics (STML) United States $0.234B 0.00
Gritstone Oncology (GRTS) United States $0.231B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Geron (GERN) United States $0.210B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.203B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 1.82
MannKind (MNKD) United States $0.200B 0.00
Alcobra (ARCT) United States $0.192B 0.00
Starpharma Holdings (SPHRY) Australia $0.186B 0.00
ChromaDex (CDXC) United States $0.185B 0.00
XOMA (XOMA) United States $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.171B 0.00
HOOKIPA Pharma (HOOK) United States $0.168B 0.00
Selecta Biosciences (SELB) United States $0.164B 0.00
VBI Vaccines (VBIV) United States $0.164B 0.00
IVERIC Bio (ISEE) United States $0.159B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
OSMOTICA PHARM (OSMT) United States $0.154B 0.00
Prometic Life Sciences (LMNL) Canada $0.151B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Fortress Biotech (FBIO) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.143B 0.00
Dyadic (DYAI) United States $0.138B 0.00
AIT Therapeutics (XAIR) United States $0.136B 0.00
Theratechnologies (THTX) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.131B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.127B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Affimed (AFMD) Germany $0.125B 0.00
Cerecor (CERC) United States $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Exicure (XCUR) United States $0.118B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.114B 4.49
Enzo Biochem (ENZ) United States $0.107B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 0.00
IBio (IBIO) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.099B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.096B 2.61
OvaScience (MLND) United States $0.091B 0.00
Aptinyx (APTX) United States $0.089B 0.00
TELA Bio (TELA) United States $0.088B 0.00
PHASEBIO PHARMA (PHAS) United States $0.087B 0.00
Orgenesis (ORGS) United States $0.081B 4.72
CorMedix Inc (CRMD) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Five Prime Therapeutics (FPRX) United States $0.077B 0.00
Happiness Biotech Group (HAPP) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Arbutus Biopharma (ABUS) Canada $0.069B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Eton Pharmaceuticals (ETON) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Cyclerion Therapeutics (CYCN) United States $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
SESEN BIO, INC (SESN) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Synlogic (SYBX) United States $0.051B 0.00
Trevena (TRVN) United States $0.049B 0.00
Catalyst Biosciences (CBIO) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.047B 0.00
Stealth BioTherapeutics (MITO) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.041B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.034B 0.00
Organovo Holdings (ONVO) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Lumos Pharma (LUMO) United States $0.032B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.032B 0.00
CollPlant Holdings (CLGN) Israel $0.032B 0.00
Advaxis (ADXS) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Celsion (CLSN) United States $0.027B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Evogene (EVGN) Israel $0.024B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Alimera Sciences (ALIM) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
Unum Therapeutics (UMRX) United States $0.011B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
ATyr Pharma (LIFE) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00